Human Genome Epidemiology Literature Finder
|
Records 1 - 24 (of 24 Records) |
| Query Trace: Disease and SPOP[original query] |
|---|
| Insight in glioma susceptibility through an analysis of 6p22.3, 12p13.33-12.1, 17q22-23.2 and 18q23 SNP genotypes in familial and non-familial glioma. Human genetics 2012 Sep 131 (9): 1507-17. Liu Yanhong, Melin Beatrice S, Rajaraman Preetha, Wang Zhaoming, Linet Martha, Shete Sanjay, Amos Christopher I, Lau Ching C, Scheurer Michael E, Tsavachidis Spiridon, Armstrong Georgina N, Houlston Richard S, Hosking Fay J, Claus Elizabeth B, Barnholtz-Sloan Jill, Lai Rose, Il'yasova Dora, Schildkraut Joellen, Sadetzki Siegal, Johansen Christoffer, Bernstein Jonine L, Olson Sara H, Jenkins Robert B, LaChance Daniel, Vick Nicholas A, Wrensch Margaret, Davis Faith, McCarthy Bridget J, Andersson Ulrika, Thompson Patricia A, Chanock Stephen, , Bondy Melissa |
| Mutation detection in formalin-fixed prostate cancer biopsies taken at the time of diagnosis using next-generation DNA sequencing. Journal of clinical pathology 2015 Mar 68 (3): 212-7. Manson-Bahr David, Ball Richard, Gundem Gunes, Sethia Krishna, Mills Robert, Rochester Mark, Goody Victoria, Anderson Elizabeth, O'Meara Sarah, Flather Marcus, Keeling Matthew, Yazbek-Hanna Marcelino, Hurst Rachel, Curley Helen, Clark Jeremy, Brewer Daniel S, McDermott Ultan, Cooper Col |
| Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1. Oncotarget 2016 Mar . Spans Lien, Van den Broeck Thomas, Smeets Elien, Prekovic Stefan, Thienpont Bernard, Lambrechts Diether, Karnes R Jeffrey, Erho Nicholas, Alshalalfa Mohammed, Davicioni Elai, Helsen Christine, Gevaert Thomas, Tosco Lorenzo, Haustermans Karin, , Joniau Steven, Claessens Fra |
| SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone Sensitivity. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 Aug . Boysen Gunther, Rodrigues Daniel N, Rescigno Pasquale, Seed George, Dolling David, Riisnaes Ruth, Crespo Mateus, Zafeiriou Zafeiris, Sumanasuriya Semini, Bianchini Diletta, Hunt Joanne, Moloney Deirdre, Perez-Lopez Raquel, Tunariu Nina, Miranda Susana, Figueiredo Inês, Ferreira Ana, Christova Rossitza, Gil Veronica, Aziz Sara, Bertan Claudia, de Oliveira Flavia M, Atkin Mark, Clarke Matthew, Goodall Jane, Sharp Adam, MacDonald Theresa, Rubin Mark A, Yuan Wei, Barbieri Christopher E, Carreira Suzanne, Mateo Joaquin, de Bono Johann |
| Downregulation of IQGAP2 Correlates with Prostate Cancer Recurrence and Metastasis. Translational oncology 2018 11 12 (2): 236-244. Xie Yanyun, Zheng Linfeng, Tao Liji |
| Mutations in ATM, NBN and BRCA2 predispose to aggressive prostate cancer in Poland. International journal of cancer 2020 Sep . Woko?orczyk Dominika, Klu?niak Wojciech, Huzarski Tomasz, Gronwald Jacek, Szymiczek Agata, Rusak Bogna, Stempa Klaudia, Gliniewicz Katarzyna, Kashyap Aniruddh, Morawska Sylwia, D?bniak Tadeusz, Jakubowska Anna, Szwiec Marek, Domaga?a Pawe?, Lubi?ski Jan, Narod Steven A, Akbari Mohammad R, Cybulski Cezary, |
| Alzheimer Gene BIN1 may Simultaneously Influence Dementia Risk and Androgen Deprivation Therapy Dosage in Prostate Cancer. American journal of clinical oncology 2020 6 43 (10): 685-689. Lehrer Steven, Rheinstein Peter |
| Co-occurrent Alterations of Alzheimer's Genes and Prostate Cancer Genes in Prostate Cancer. Cancer genomics & proteomics 0 17 (3): 271-275. Lehrer Steven, Rheinstein Peter |
| Identification of Metabolism-Associated Prostate Cancer Subtypes and Construction of a Prognostic Risk Model. Frontiers in oncology 2020 12 10 598801. Zhang Yanlong, Zhang Ruiqiao, Liang Fangzhi, Zhang Liyun, Liang Xuez |
| NCOR1 may be a potential biomarker of a novel molecular subtype of prostate cancer. FEBS open bio 2020 Oct . Tang Lu, Zhang Lixia, Liu Lei, Dong Liping, Dong Yuan, Zhu Wenhe, Wang Huiy |
| CDKN1B Deletions are Associated with Metastasis in African American Men with Clinically Localized, Surgically Treated Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2020 Jan . Faisal Farzana A, Murali Sanjana, Kaur Harsimar, Vidotto Thiago, Guedes Liana B, Salles Daniela Correia, Kothari Vishal, Tosoian Jeffrey J, Han Sumin, Hovelson Daniel H, Hu Kevin, Spratt Daniel E, Baras Alexander S, Tomlins Scott A, Schaeffer Edward M, Lotan Tamara |
| The SPOP-ITCH Signaling Axis Protects Against Prostate Cancer Metastasis. Frontiers in oncology 2021 7 11 658230. Ma Jinlu, Cai Mengjiao, Mo Yaqi, Fried Joshua S, Tan Xinyue, Ma Yuan, Chen Jie, Han Suxia, Xu |
| Clinicopathologic and Genomic Analysis of TP53-Mutated Endometrial Carcinomas. Clinical cancer research : an official journal of the American Association for Cancer Research 2021 2 27 (9): 2613-2623. Momeni-Boroujeni Amir, Dahoud Wissam, Vanderbilt Chad M, Chiang Sarah, Murali Rajmohan, Rios-Doria Eric V, Alektiar Kaled M, Aghajanian Carol, Abu-Rustum Nadeem R, Ladanyi Marc, Ellenson Lora H, Weigelt Britta, Soslow Robert |
| Early-onset metastatic and clinically advanced prostate cancer is a distinct clinical and molecular entity characterized by increased TMPRSS2-ERG fusions. Prostate cancer and prostatic diseases 2021 Jan . Chalmers Zachary R, Burns Michael C, Ebot Ericka M, Frampton Garrett M, Ross Jeffrey S, Hussain Maha H A, Abdulkadir Sarki |
| SPOP Mutations as a Predictive Biomarker for Androgen Receptor Axis-Targeted Therapy in De Novo Metastatic Castration-Sensitive Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 9 28 (22): 4917-4925. Swami Umang, Graf Ryon P, Nussenzveig Roberto H, Fisher Virginia, Tukachinsky Hanna, Schrock Alexa B, Li Gerald, Ross Jeffrey S, Sayegh Nicolas, Tripathi Nishita, Mathew Thomas Vinay, Oxnard Geoffrey R, Antonarakis Emmanuel S, Agarwal Neer |
| Determination of ERG(+), EZH2, NKX3.1, and SPINK-1 subtypes to evaluate their association with clonal origin and disease progression in multifocal prostate cancer. Cancer reports (Hoboken, N.J.) 2022 10 e1728. Segura-Moreno Yenifer Yamile, Sanabria-Salas María Carolina, Mesa-López De Mesa Jorge Andrés, Varela-Ramirez Rodolfo, Acosta-Vega Natalia Lizeth, Serrano Martha Luc |
| Molecular features of prostate cancer post-neoadjuvant therapy in the Phase 3 CALGB 90203 trial. Journal of the National Cancer Institute 2023 9 . Takayuki Sumiyoshi, Xiaofei Wang, Evan W Warner, Andrea Sboner, Matti Annala, Michael Sigouros, Kevin Beja, Kei Mizuno, Shengyu Ku, Ladan Fazli, James Eastham, Mary-Ellen Taplin, Jeffrey Simko, Susan Halabi, Michael J Morris, Martin E Gleave, Alexander W Wyatt, Himisha Beltr |
| Clinical significance of SPOP and APC gene alterations in colorectal cancer in Indian population. Molecular genetics and genomics : MGG 2023 6 . Asgar Ali, Nimisha, Abhay Kumar Sharma, Pramod Kumar Mishra, Sundeep Singh Salu |
| Somatic and Germline Variants Affect Prognosis and Susceptibility in Prostate Cancer. Anticancer research 2023 6 43 (7): 2941-2949. Christian Rocca, Giulia Rocca, Pietro Zampieri, Lucio Dell'atti, Nicoletta Bianchi, Carmelo Ippolito, Gianluca Aguia |
| Determination of TMPRSS2-ERG, SPOP, FOXA1, and IDH1 prostate cancer molecular subtypes in Colombian patients and their possible implications for prognosis. Cell biology international 2023 2 . Montero-Ovalle Wendy, Sanabria-Salas María C, Mesa-López de Mesa Jorge, Varela-Ramírez Rodolfo, Segura-Moreno Yenifer Y, Sánchez-Villalobos Santiago A, Nuñez-Lemus Marcela, Serrano Martha |
| Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer. European urology oncology 2023 12 . Jacob J Orme, Fadi Taza, Navonil De Sarkar, Alok K Tewari, Syed Arsalan Naqvi, Irbaz B Riaz, Daniel S Childs, Noha Omar, Nabil Adra, Ryan Ashkar, Heather H Cheng, Michael T Schweizer, Alexandra O Sokolova, Neeraj Agarwal, Pedro Barata, Oliver Sartor, Diogo Bastos, Oren Smaletz, Jacob E Berchuck, Heather McClure, Mary-Ellen Taplin, Rahul Aggarwal, Cora N Sternberg, Panagiotis J Vlachostergios, Ajjai S Alva, Niven Mehra, Peter S Nelson, Justin Hwang, Scott M Dehm, Qian Shi, Zoe Fleischmann, Ethan S Sokol, Andrew Elliott, Haojie Huang, Alan Bryce, Catherine H Marshall, Emmanuel S Antonarak |
| Metastatic prostate cancer is associated with distinct higher frequency of genetic mutations at diagnosis. Urologic oncology 2023 10 . Mohammed Al-Toubat, Samuel Serrano, Ahmed Elshafei, Kashyap Koul, Allison H Feibus, K C Bala |
| The Mutational and Transcriptional Landscapes of Speckle-Type POZ Protein (SPOP) and Androgen Receptor (AR) in a Single-Center pT3 Prostatectomy Cohort. Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer 2023 10 43 (1): 15-29. Isil Ezgi Eryilmaz, Berna Aytac Vuruskan, Onur Kaygisiz, Gulsah Cecener, Unal Egeli, Hakan Vurusk |
| Clinical implications of Wnt pathway genetic alterations in men with advanced prostate cancer. Prostate cancer and prostatic diseases 2024 7 . Amanda Broderick, Elizabeth Pan, Jinju Li, Alec Chu, Clara Hwang, Pedro C Barata, Frank Cameron Cackowski, Matthew Labriola, Alyssa Ghose, Mehmet Asim Bilen, Deepak Kilari, Bicky Thapa, Michael Piero, Laura Graham, Abhishek Tripathi, Rohan Garje, Vadim S Koshkin, Erik Hernandez, Tanya B Dorff, Michael Thomas Schweizer, Ajjai Shivaram Alva, Rana R McKay, Andrew J Armstro |
- Page last reviewed:Feb 1, 2024
- Content source: